Research Index | Medline Index
Cannabis Research - driving and testing
- Authors
- Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM
- Title
- Incidence and toxicological aspects of drugs detected in 484 fatally
injured drivers and pedestrians in Ontario.
- Source
- Journal of Forensic Sciences
- Date
- 1982 Oct
- Issue
- 27(4)
- Pages
- 855-67
- Abstract
- Results are presented of a comprehensive drug study carried out on
specimens from drivers and pedestrians fatally injured in Ontario.
Toxicological analyses were regularly performed on blood and urine
and occasionally on vitreous humor, stomach contents, and liver. The
analytical procedures could detect and quantitate a wide variety of
drugs including such illicit drugs as Cannabis. With respect to
drivers, alcohol was found in 57% of the study sample and drugs
other than alcohol, in 26%. However, in only 9.5% of the drivers
were psychoactive drugs (other than alcohol) detected in the blood
in concentrations that may adversely affect driving skills.
Delta-9-Tetrahydrocannabinol and diazepam accounted for a majority
of the findings in this category.
- Authors
- Dackis CA, Pottash AL, Annitto W, Gold MS
- Title
- Persistence of urinary marijuana levels after supervised abstinence.
- Source
- American Journal of Psychiatry
- Date
- 1982 Sep
- Issue
- 139(9)
- Pages
- 1196-8
- Abstract
- The authors present a case report of the presence of urinary
cannabinoids during 21 days of supervised abstinence from chronic
marijuana use and provide data on 6 similar cases. They discuss the
theoretical implications of the persistence of cannabinoids.
- Authors
- Mason AP, McBay AJ
- Title
- Ethanol, marijuana, and other drug use in 600 drivers killed in
single-vehicle crashes in North Carolina, 1978-1981.
- Source
- Journal of Forensic Sciences
- Date
- 1984 Oct
- Issue
- 29(4)
- Pages
- 987-1026
- Abstract
- Although the use of ethanol, marijuana, and other drugs may be
detrimental to driving safety, this has been established by direct
epidemiological evidence only for ethanol. In this study, the
incidences of detection of ethanol (and other volatile substances),
delta-9-tetrahydrocannabinol (THC), barbiturates, cocaine and
benzoylecgonine, opiates, and phencyclidine were determined in an
inclusive population of 600 verified single-vehicle operator
fatalities that occurred in North Carolina in 1978 to 1981. The
incidence of detection of amphetamines and methaqualone were
determined for drivers accepted for study during the first two years
(n = 340) and the last year (n = 260), respectively. Blood
concentrations of 11-nor-deta-9-tetrahydrocannabinol-9-carboxylic
acid (9-carboxy-THC) were determined in THC positive drivers. EMIT
cannabinoid assays were performed on blood specimens from all
drivers accepted for study during the third year, and the
feasibility of using the EMIT cannabinoid assay as a screening
method for cannabinoids in forensic blood specimens was
investigated. The incidence of detection of ethanol (79.3%) was far
greater than the incidences determined for THC (7.8%), methaqualone
(6.2%), and barbiturates (3.0%). Other drugs were detected rarely,
or were not detected. Blood ethanol concentrations (BECs) were
usually high; 85.5% of the drivers whose bloods contained ethanol
and 67.8% of all drivers had BECs greater than or equal to 1.0 g/L.
Drug concentrations were usually within or were below accepted
therapeutic or active ranges. Only a small number of drivers could
have been impaired by drugs, and most of them had high BECs.
Multiple drug use (discounting ethanol) was comparatively rare.
Ethanol was the only drug tested for that appears to have a
significantly adverse effect on driving safety.
- Authors
- Gjerde H, Kinn G
- Title
- Impairment in drivers due to cannabis in combination with other
drugs.
- Source
- Forensic Science International
- Date
- 1991 Jul-Aug
- Issue
- 50(1)
- Pages
- 57-60
- Abstract
- Blood samples from 425 suspected drugged drivers who were clinically
impaired and negative for alcohol were analysed. Fifty-six percent
of the samples were positive for tetrahydrocannabinol (THC).
Tetrahydrocannabinol-positive blood samples were analysed for
amphetamines, barbiturates, benzodiazepines, cocaine metabolites and
opiates. Eighty-two percent of the samples were found to be positive
for one or more drugs in addition to THC, and the concentrations of
these drugs were often high. Thus, THC in combination with other
drugs seems to be a much more frequent reason for impairment than
THC alone among Norwegian drugged drivers.
- Id Code
- 91037852
- Authors
- Cimbura G, Lucas DM, Bennett RC, Donelson AC
- Title
- Incidence and toxicological aspects of cannabis and ethanol detected
in 1394 fatally injured drivers and pedestrians in Ontario
(1982-1984).
- Source
- Journal of Forensic Sciences
- Date
- 1990 Sep
- Issue
- 35(5)
- Pages
- 1035-41
- Abstract
- A comprehensive epidemiological study of the involvement of cannabis
and ethanol in motor vehicle fatalities in the Province of Ontario,
Canada, is described. The study is based on toxicological analyses
of blood and, when available, urine specimens. Ethanol was
determined by headspace gas chromatography (GC). For cannabis, the
methods employed were radioimmunoassays (RIAs) for screening and gas
chromatography/mass spectrometry (GC/MS) for the determination of
delta-9-tetrahydrocannabinol (THC) in blood. The study sample
consisted of 1169 drivers and 225 pedestrians. THC was detected in
the blood of 127 driver victims (10.9%) in concentrations ranging
from 0.2 to 37 ng/mL, with a mean of 3.1 +/- 5.0 ng/mL. Ethanol was
found in 667 driver victims (57.1%), in concentrations ranging from
9 to 441 mg/100 mL, with a mean of 165.8 +/- 79.5 mg/100 mL. For
pedestrians, the incidence of THC and ethanol in the blood was 7.6
and 53.3%, respectively. The incidence of THC in the driver victims
in this study constitutes an approximately threefold increase over
the results of an Ontario study completed in 1979. At least a part
of the increase may be attributed to interstudy differences in
analytical methodology for cannabinoids.
- Id Code
- 90083545
- Authors
- Marks DF, MacAvoy MG
- Title
- Divided attention performance in cannabis users and non-users
following alcohol and cannabis separately and in combination.
- Source
- Psychopharmacology
- Date
- 1989
- Issue
- 99(3)
- Pages
- 397-401
- Abstract
- The effect of delta 9-tetrahydrocannabinol (delta 9-THC) and
alcohol, singly and in combination, on divided attention performance
was investigated in cannabis users and non-users who were matched
for alcohol use. Both cannabis and alcohol produced decrements in
central and peripheral signal detections. Drug and alcohol effects
were greater for signal presentations in the periphery. Cannabis
users were less impaired in peripheral signal detection than
non-users while intoxicated by cannabis and/or alcohol. These
findings suggest the development of tolerance and cross-tolerance in
regular cannabis users and/or the ability to compensate for
intoxication effects.
- Id Code
- 89196217
- Authors
- Budd RD, Muto JJ, Wong JK
- Title
- Drugs of abuse found in fatally injured drivers in Los Angeles
County.
- Source
- Drug & Alcohol Dependence
- Date
- 1989 Apr
- Issue
- 23(2)
- Pages
- 153-8
- Abstract
- Blood or urine specimens from nearly 600 fatally injured drivers in
two Los Angeles County studies were analyzed for the presence of
alcohol and other drugs of abuse, including PCP, cocaine, opiates
and marijuana. The results of the preliminary study indicate that 65
out of 102 fatally injured drivers had used alcohol and/or another
drug of abuse - 34 had used alcohol only, 12 had used one or more
other drug(s) of abuse, and 19 had used alcohol in combination with
another drug of abuse. The results of the larger follow-up study,
begun a year later, indicate a continued high level of both alcohol
use (41.5%) and marijuana use (19%) with moderate cocaine usage (8%)
and low levels (less than 2%) of barbiturate and PCP usage.
- Id Code
- 92311891
- Authors
- Kielland KB
- Title
- [Urinary excretion of cannabis metabolites].
- Language
- Norwegian
- Source
- Tidsskrift for Den Norske Laegeforening
- Date
- 1992 May 10
- Issue
- 112(12)
- Pages
- 1585-6
- Abstract
- Urine testing is increasingly used to detect drug abuse, most
commonly by easily performed immunological tests. There is large
interpersonal variation in the excretion time of cannabinoids.
Excretion times of up to 11 weeks have been demonstrated. In cases
with a long excretion time a negative test result may be followed by
a positive result without concomitant abuse. We describe a case
where cannabinoid metabolites in urine were detected by a routine
immunological method (Abbotts ADx) after 95 days of supervised
abstinence. It is important that personnel evaluating test results
have a thorough knowledge of possible pitfalls.
- Authors
- - Logan BK, Schwilke EW
- Title
- - Drug and alcohol use in fatally injured drivers in Washington State.
- Language
- - Eng
- Date
- - 1996 May
- Issue
- - 0022-1198
- Source
- - J Forensic Sci
- Pages
- - 505-10
- Country
- - UNITED STATES
- Abstract
- - Blood and/or urine from fatally injured drivers in Washington State
were collected and tested for the presence of drugs and alcohol. Drug
and/or alcohol use was a factor in 52% of all fatalities. Among single
vehicle accidents, alcohol use was a factor in 61% of cases versus 30%
for multiple vehicle accidents. Drugs most commonly encountered were
marijuana (11%), cocaine (3%), amphetamines (2%), together with a
variety of depressant prescription medications. Trends noted included
an association of depressant use with higher blood alcohol levels,
while marijuana use was associated with lower blood alcohol levels.
Marijuana use was noted to be most prominent in the 15-30 year age
group, stimulant use in the 21-40 year old group, and prescription
depressant use was more prevelant in the 45 + age group. Drug use
demographics in this population are consistent with those noted in
other jurisdictions.
- Research Institute
- - Department of Laboratory Medicine, University of Washington, Seattle,
98134-2027, USA.
- Source
- - J Forensic Sci 1996 May;41(3):505-10
- Authors
- - Sugrue M, Seger M, Dredge G, Davies DJ, Ieraci S, Bauman A, Deane SA, Sloane D
- Title
- - Evaluation of the prevalence of drug and alcohol abuse in motor vehicle
trauma in south western Sydney.
- Language
- - Eng
- Date
- - 1995 Dec
- Issue
- - 0004-8682
- Source
- - Aust N Z J Surg
- Pages
- - 853-6
- Country
- - AUSTRALIA
- Abstract
- - This study estimated prospectively the prevalence of high drug and
alcohol levels in road trauma cases who met the criteria for activation
of the Liverpool Hospital's trauma team. Urine analysis of road trauma
victims between October 1992 and October 1993 was undertaken for drug
and alcohol estimation. A total of 164 drivers were studied. A urine
alcohol concentration (UAC) exceeding 0.08 g/dL was detected in 27
drivers (16.5%). Cannabinoids were detected in the urine of 25 drivers
(15.2%), in 17 the concentrations exceeded 400 ng/mL. In one instance
amphetamine, cocaine and heroin were detected in the same injured
driver. Combined use of alcohol with some other drugs was detected in
only four drivers. Alcohol and cannabinoid levels were prevalent in the
urine of injured drivers in this study, particularly in young males who
remain over-represented in the group of injured drivers. In the
population surveyed other drugs were rarely detected. The role of
cannabinoids in road trauma and the use of cannabinoids in young male
drivers will however need to be monitored more extensively.
- Research Institute
- - Department of Trauma, Liverpool Hospital, Sydney, New South Wales,
Australia.
- Source
- - Aust N Z J Surg 1995 Dec;65(12):853-6
- Authors
- - Marquet P, Delpla PA, Kerguelen S, Bremond J, Facy F, Garnier M, Guery B, Lhermitte M, Mathe D, Pelissier AL, Renaudeau C, Vest P, Seguela JP
- Title
- - Prevalence of drugs of abuse in urine of drivers involved in road
accidents in France: a collaborative study.
- Language
- - Eng
- Date
- - 1998 Jul
- Issue
- - 0022-1198
- Source
- - J Forensic Sci
- Pages
- - 806-11
- Country
- - UNITED STATES
- Abstract
- - The collaborative, anonymous, case-control study was intended to
determine the prevalence of opiates, cocaine metabolites, cannabinoids
and amphetamines in the urine of drivers injured in road accidents and
to compare these values with those of non-accident subjects
("patients") in France. Recruitment was performed nationwide in the
emergency departments of five hospitals and comprised 296 "drivers"
aged 18 to 35 and 278 non-traumatic "patients" in the same age range.
Females represented 28.4% of "drivers" and 44.2% of "patients."
Screening for drugs in urine was performed by fluorescence polarization
immunoassays in each center. Each positive result was verified using
gas chromatography-mass spectrometry (GC-MS), in a single laboratory.
Statistical analysis comprised single-step logistic regression and
simultaneously took account of confounding factors and the final
differences in prevalence values between the two populations or
different subgroups. Cannabinoids were found in 13.9% of drivers (16.0%
of males and 8.3% of females, p < 0.05) and 7.5% of patients (12.3% of
males, 1.6% of females, p < 0.0001); only in females was this
prevalence higher in injured drivers than in patients (p < 0.05).
Opiates were present in 10.5% of drivers' and 10.4% of patients' urine
samples (NS), and were more frequent in urine samples positive for
cannabinoids, in drivers (p < 0.01) as well as in patients (p < 0.001).
The prevalence of cocaine metabolites in drivers and patients was 1.0
and 1.1% and that of amphetamines 1.4 and 2.5%, respectively. No causal
relationship between drugs and accidents should be inferred from this
retrospective study. Nevertheless, the high prevalence of cannabis and
opiate (licit or illicit) use in young people, whether injured drivers
or patients, has potential implications for road traffic safety in
France. Cocaine and amphetamines did not appear to be a major problem,
unlike the experience in other countries.
- Research Institute
- - Department of Pharmacology-Toxicology and Emergency Care Unit,
University Hospital, Limoges, France.
- Source
- - J Forensic Sci 1998 Jul;43(4):806-11
- Authors
- - Costantino A, Schwartz RH, Kaplan P
- Title
- - Hemp oil ingestion causes positive urine tests for delta 9-
tetrahydrocannabinol carboxylic acid.
- Language
- - Eng
- Date
- - 1997 Oct
- Issue
- - 0146-4760
- Source
- - J Anal Toxicol
- Pages
- - 482-5
- Country
- - UNITED STATES
- Abstract
- - A hemp oil product (Hemp Liquid Gold) was purchased from a specialty
food store. Fifteen milliliters was consumed by seven adult volunteers.
Urine samples were taken from the subjects before ingestion and at 8,
24, and 48 h after the dose was taken. All specimens were screened by
enzyme immunoassay with SYVA EMIT II THC 20, THC 50, and THC 100 kits.
The tetrahydrocannabinol carboxylic acid (THCA) concentration was
determined on all samples by gas chromatography-mass spectrometry (GC-
MS) (5). A total of 18 postingestion samples were submitted. Fourteen
of the samples screened above the 20-ng cutoff, seven were above the 50-
ng cutoff, and two screened greater than the 100-ng cutoff. All of the
postingestion samples showed the presence of THCA by GC-MS.
- Research Institute
- - American Medical Laboratory, Chantilly, Virginia 20151, USA.
- Source
- - J Anal Toxicol 1997 Oct;21(6):482-5
- Authors
- - Fortner N, Fogerson R, Lindman D, Iversen T, Armbruster D
- Title
- - Marijuana-positive urine test results from consumption of hemp seeds in
food products.
- Language
- - Eng
- Date
- - 1997 Oct
- Issue
- - 0146-4760
- Source
- - J Anal Toxicol
- Pages
- - 476-81
- Country
- - UNITED STATES
- Abstract
- - Commercially available snack bars and other foodstuffs prepared from
pressed hemp seeds were ingested by volunteers. Urine specimens were
collected for 24 h after ingestion of the foodstuffs containing hemp
seeds and tested for marijuana using an EMIT immunoassay and gas
chromatography-mass spectrometry (GC-MS). Specimens from individuals
who ate one hemp seed bar demonstrated little marijuana
immunoreactivity, and only one specimen screened positive at a 20-ng/mL
cutoff. Specimens from individuals who ate two hemp seed bars showed
increased immunoreactivity, and five specimens screened positive at a
20-ng/mL cutoff. A single specimen yielded a quantitative GC-MS value
(0.6 ng/mL), but it failed to meet reporting criteria. Several
specimens from individuals who ate three cookies made from hemp seed
flour and butter screened positive at both 50- and 20-ng/mL cutoffs.
Two specimens produced quantitative GC-MS values (0.7 and 3.1 ng/mL),
but they failed to meet reporting criteria. Several specimens also
tested positive with an FDA-approved on-site marijuana-screening
device. Hemp seeds similar to those used in the foodstuffs did not
demonstrate the presence of marijuana when tested by GC-MS. In this
study, ingestion of hemp seed food products resulted in urine specimens
that screened positive for marijuana. No specimens gave a GC-MS
quantitative value above the limit of detection for marijuana.
- Research Institute
- - PharmChem Laboratories, Inc., Menlo Park, California 94025, USA.
- Source
- - J Anal Toxicol 1997 Oct;21(6):476-81
- Authors
- - Lehmann T, Sager F, Brenneisen R
- Title
- - Excretion of cannabinoids in urine after ingestion of cannabis seed oil
[see comments]
- Language
- - Eng
- Date
- - 1997 Sep
- Issue
- - 0146-4760
- Source
- - J Anal Toxicol
- Pages
- - 373-5
- Country
- - UNITED STATES
- Abstract
- - Gas chromatographic-mass spectrometric (GC-MS) quantitation of 25
cannabis sed oils determined delta 9-tetrahydrocannabinol (THC)
concentrations from 3 to 1500 micrograms/g oil. In a pilot study, the
morning urine of six volunteers who had ingested 11 or 22 g of the oil,
which contained the highest THC content (1500 micrograms/g), was
collected for six days. The urine samples were screened by immunoassay,
and the content of 11-nor-9-carboxy-delta 9-THC (THCCOOH) was
determined by GC-MS. Urine samples were found cannabis positive for up
to six days with THCCOOH-equivalent concentrations up to 243 ng/mL. by
the Abuscreen OnLine immunoassay and THCCOOH contents from 5 to 431
ng/mL by the GC-MS method. All subjects reported THC-specific
psychotropic effects.
- Research Institute
- - Institute of Pharmacy, University of Bern, Switzerland.
- Comment
- - Comment in: J Anal Toxicol 1998 Jan-Feb;22(1):80-1
- Source
- - J Anal Toxicol 1997 Sep;21(5):373-5
- Authors
- - Struempler RE, Nelson G, Urry FM
- Title
- - A positive cannabinoids workplace drug test following the ingestion of
commercially available hemp seed oil [see comments]
- Language
- - Eng
- Date
- - 1997 Jul-Aug
- Issue
- - 0146-4760
- Source
- - J Anal Toxicol
- Pages
- - 283-5
- Country
- - UNITED STATES
- Abstract
- - A commercially available health food product of cold-pressed hemp seed
oil ingested by one volunteer twice a day for 4 1/2 days (135 mL
total). Urine specimens collected from the volunteer were subjected to
standard workplace urine drug testing procedures, and the following
concentrations of 11-nor-delta9- tetrahydrocannabinol carboxylic acid
(9-THCA) were detected: 41 ng/mL 9-THCA at 45 h, 49 ng/mL at 69 h, and
55 ng/mL at 93 h. Ingestion was discontinued after 93 h, and the
following concentrations were detected: 68 ng/mL at 108 h, 57 ng/mL at
117 h, 31 ng/mL at 126 h, and 20 ng/mL at 142 h. The first specimen
that tested negative (50 ng/mL initial immunoassay test, 15 ng/mL
confirmatory gas chromatographic-mass spectrometric test) was at 146 h,
which was 53 h after the last hemp seed oil ingestion. Four subsequent
specimens taken to 177 h were also negative. This study indicates that
a workplace urine drug test positive for cannabinoids may arise from
the consumption of commercially available cold-pressed hemp seed oil.
- Research Institute
- - ARUP Laboratories, Inc., Salt Lake City, Utah 84108, USA.
- Comment
- - Comment in: J Anal Toxicol 1998 Jan-Feb;22(1):80-1
- Source
- - J Anal Toxicol 1997 Jul-Aug;21(4):283-5